Dokumentdetails
ID
oai:pubmedcentral.nih.gov:1079...
Thema
ArticleAutor
Wang, James Seo, Jai Woong Kare, Aris J. Schneider, Martin Tumbale, Spencer K. Wu, Bo Raie, Marina N. Pandrala, Mallesh Iagaru, Andrei Brunsing, Ryan L. Charville, Gregory W. Park, Walter G. Ferrara, Katherine W.Langue
enEditor
Cold Spring Harbor Laboratory
Kategorie
biorxiv
Jahr
2024
Auflistungsdatum
24.01.2024
Schlüsselwörter
cancer claudin-4 markers spatialZusammenfassung
We apply spatial transcriptomics and proteomics to select pancreatic cancer surface receptor targets for molecular imaging and theranostics using an approach that can be applied to many cancers.
Selected cancer surfaceome epithelial markers were spatially correlated and provided specific cancer localization, whereas the spatial correlation between cancer markers and immune- cell or fibroblast markers was low.
While molecular imaging of cancer-associated fibroblasts and integrins has been proposed for pancreatic cancer, our data point to the tight junction protein claudin-4 as a theranostic target.
Claudin-4 expression increased ∼16 fold in cancer as compared with normal pancreas, and the tight junction localization conferred low background for imaging in normal tissue.
We developed a peptide-based molecular imaging agent targeted to claudin-4 with accumulation to ∼25% injected activity per cc (IA/cc) in metastases and ∼18% IA/cc in tumors.
Our work motivates a new approach for data-driven selection of molecular targets.
Wang, James,Seo, Jai Woong,Kare, Aris J.,Schneider, Martin,Tumbale, Spencer K.,Wu, Bo,Raie, Marina N.,Pandrala, Mallesh,Iagaru, Andrei,Brunsing, Ryan L.,Charville, Gregory W.,Park, Walter G.,Ferrara, Katherine W., 2024, Spatial transcriptomic analysis drives PET imaging of tight junction protein expression in pancreatic cancer theranostics , Cold Spring Harbor Laboratory
MELAS: Phenotype Classification into Classic-versus-Atypical Presentations
presentations mitochondrial strokelike patients variability phenotype clinical melas
